Beruflich Dokumente
Kultur Dokumente
Caused by a flavi-virus
Four serotypes
Infection produces immunity to only
one serotype
No specific treatment
CAUSES OF DEATH
IMMEDIATE
CAUSE OF DEATH
NUMBER OF CASES
AND PERCENTAGE (%)
Shock Syndrome
65 (70%)
49 (53%)
Severe Bleeding
36 (39%)
3.
NUMBER OF
CASES AND
PERCENTAGE (%)
40 (43%)
59 (64%)
37 (40%)
19 (21%)
Late referral
18 (20%)
15 (16%)
14 (15%)
70 (76%)
38 (41%)
29 (32%)
25 (27%)
26 (28%)
21(23%)
16 (17%)
18 (20%)
Clinical symptoms
Non specific
Myalgia, athralgia
Anorexia
Rash may or may not be present
Without
with
warning
signs
Warning signs*
Abdominal pain or
tenderness
Persistent vomiting
Clinical fluid
accumulation
Mucosal bleed
Lethargy; restlessness
Liver enlargement >2cm
Laboratory: Increase in
HCT concurrent with rapid
decrease in platelet count
* Requiring strict
observation
Severe dengue
WHO/TDR 2009
Dengue warning
signs
Atypical presentations
Diarrhoea
ILI
Myocarditis
Encephalitis
Severe bleeding without plasma
leakage
Myositis
Clinical course
Pathophysiology
Capillary leakage
Leakage of serum into the 3rd space ie
pleural cavity, acsites etc
Resulting in intravascular volume
depletion
Reflected in increasing HCT
Diagnostic tests
Dengue Serology
ELISA method : Ig M and Ig G
Ig M only positive after 5 days 30 to
90 days
Ig G appear later, can be higher in
secondary infection
Laboratory Investigations
Full blood count
Low WBC
Haematocrit or PCV
Marker of plasma leakage
Differentiate DF from DHF
Thrombocytopaenia
More severe disease lower counts
Not predictive of bleeding
Liver function test
Raised AST and ALT
Higher in DHF
In patient management
Frequent monitoring
Vital signs
BP, PR, RR, T, pulse pressure
Capillary refill time, pulse volume
Clinical signs
Abdomen tenderness and pain
Vomiting
Pleural effusion
FBC
PCV
Platelet
Mm Hg
Pulse rate
120
110
100
90
80
70
60
Compensated shock
Decompensated shock
Time
LCS Lum
Dengue infection
Reduced intravascular
volume
Shock
Metabolic acidosis
Major Bleeding
Recovery phase
After critical phase leakage will stop
Reabsorption will start fluid in the
3rd space will start moving back into
the intravascular space
Reflected by a gradual decline in HCT
Intravascular
space
3rd space ie
ascites, pleural
effusion
MANAGEMENT AS
OUTPATIENT
IF ADMISSION NOT
INDICATED
WHAT NEXT?
Daily or more frequent f/u from day 3 of
illness until afebrile for at least 2448
hours
Provide Dengue monitoring record & Home
Care Advice Leaflet
Include fluid advice
Advise patient to return to hospital as soon
as the warning signs develops
Symptoms:
1. Warning signs
2. Bleeding
manifestations
3. Inability to
tolerate oral fluids
4. Reduced urine
output
5. Seizure
Signs:
1. Dehydration
2. Shock
3. Bleeding
4. Any organ failure
CASE STUDY
WT : 65 kg
Temp 38.2
HR 80-90 per minute
BP 130/80
NS1 positive
Warm peripheries
CRT < 2 seconds
How much fluids to give?
Day 4 of illness
Temp 37.2
Still poor appetite and vomited x 1
Appears lethargic
HR 100/min
BP 120/80
HB 14.8
TWC 3.4
PCV 48% (42)
Plat 70 (110)
hemoconcentration
HB 14
PCV 45% (48)
Plat 50 (70)
TWC 3.2
Looks unwell
Vomitted x 2
Temp 37
BP : 100/90
HR 110/min
CRT > 2 seconds
FBC
HB 12 (14)
PCV 36% (45)
Plat 45 (50)
HCO3 : 16
Lactate : 4.3
What is going on?
After 1 pint of PC
HB 13 (12)
PCV 42 (36)
Plat 45
HR 90 /min
BP 115/80
HCO3 19, lactate 3.0
Pt is more alert now
Temp 36.9
BP 120/90
HR 80/min
CRT < 2 seconds
HB 12.5 (12)
PCV 41% (42)
Plat 50 (45)
IVD 117 mls/H (1.5 x maintenance)
Thank you